Advanced Therapies Integrates
Headline Sponsor:
Enabling Strategic Debate and Collaboration Across the Advanced Therapies and Medicinal Products (ATMP) Industry
Innovation in pharmaceutical discovery and development is taking place at an astonishing pace. The genomics revolution and other advances have led to the emergence of highly effective, but extremely complex therapeutics, with cell and gene therapies, regenerative medicines and tissue therapies now transforming the prospects of patients and healthcare providers around the globe.
However there remain many strategic challenges to the effective development, deployment and utilisation of these ground-breaking medical technologies. Advanced Therapies Integrates will constitute a new forum, dedicated to bringing together the industry leaders to help drive and deliver the full potential ATMPs.
It will uniquely engage across the widest possible network: from pharma innovators, regulators, supply chain partners, equipment & technology providers, academia, industry associations, together with a wide array of government funding bodies and government supported pharma-focused initiatives.
Specific themes and objectives will cover deployment of the key innovations and debating challenges facing the industry including the regulatory and commercial barriers to effectively deploy such broad transformational changes.
Advanced Therapies Integrates will become the leading UK event that facilitates the translation of cutting-edge research and disruptive innovation into the wide-spread adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.
150 attendees live on the day
An in-person event with recordings of sessions available.
1
Day
70+
Speakers
150
Attendees
Core sectors covered
Development, Manufacture & Implementation
Exploring the challenges in the journey to widespread adoption of ATMPs, from efficient manufacturing to streamlined NHS implementation.
Funding & skills
Looking at funding opportunities and strategies to overcome the sector-wide skills gap.
Key Speakers from 2022

Sharon Brownlow
Chief Business Officer
Cell & Gene Therapy Catapult

Tony Khoury
Executive Vice President
Project Farma

Jane Theaker
Chief Executive Officer
PBD Biotech

Joe Healey
Chief Executive Officer and Co-Founder
NanoSyrinx
Our valued sponsors

30 November 2023
Stevenage Bioscience Catalyst
Sign up for life science integrates news
Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.